HomeCompareKEYR vs JNJ

KEYR vs JNJ: Dividend Comparison 2026

KEYR yields 253.16% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 KEYR wins by $499.07M in total portfolio value
10 years
KEYR
KEYR
● Live price
253.16%
Share price
$0.79
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$499.10M
Annual income
$280,864,846.65
Full KEYR calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — KEYR vs JNJ

📍 KEYR pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodKEYRJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, KEYR + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
KEYR pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

KEYR
Annual income on $10K today (after 15% tax)
$21,518.99/yr
After 10yr DRIP, annual income (after tax)
$238,735,119.65/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, KEYR beats the other by $238,731,133.66/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of KEYR + JNJ for your $10,000?

KEYR: 50%JNJ: 50%
100% JNJ50/50100% KEYR
Portfolio after 10yr
$249.57M
Annual income
$140,434,768.02/yr
Blended yield
56.27%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

KEYR
No analyst data
Altman Z
-19.1
Piotroski
3/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

KEYR buys
0
JNJ buys
0
No recent congressional trades found for KEYR or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricKEYRJNJ
Forward yield253.16%2.13%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$499.10M$30.3K
Annual income after 10y$280,864,846.65$4,689.40
Total dividends collected$475.92M$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: KEYR vs JNJ ($10,000, DRIP)

YearKEYR PortfolioKEYR Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$36,016$25,316.46$10,592$272.30+$25.4KKEYR
2$123,753$85,215.79$11,289$357.73+$112.5KKEYR
3$406,064$273,648.14$12,123$472.89+$393.9KKEYR
4$1,273,652$839,163.06$13,141$629.86+$1.26MKEYR
5$3,822,714$2,459,906.05$14,408$846.81+$3.81MKEYR
6$10,990,410$6,900,106.08$16,021$1,151.60+$10.97MKEYR
7$30,299,925$18,540,187.18$18,122$1,588.22+$30.28MKEYR
8$80,191,226$47,770,305.60$20,930$2,228.20+$80.17MKEYR
9$203,961,633$118,157,021.52$24,792$3,191.91+$203.94MKEYR
10$499,103,794$280,864,846.65$30,274$4,689.40+$499.07MKEYR

KEYR vs JNJ: Complete Analysis 2026

KEYRStock

KeyStar Corp. offers e-commerce and convention services in the United States. The company engages in the online retail and wholesale of merchandise. It primarily sells KN-95 facemasks, disposable facemasks, and disinfectant wipes through an online store. The company also offers convention services, which connect US buyers to Chinese manufacturers. In addition, it provides trade show booth staffing, designing, and manufacturing services through KeyStarCorp.com. The company was incorporated in 2020 and is based in Las Vegas, Nevada.

Full KEYR Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this KEYR vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

KEYR vs SCHDKEYR vs JEPIKEYR vs OKEYR vs KOKEYR vs MAINKEYR vs ABBVKEYR vs MRKKEYR vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.